SUBSCRIBE
SUBSCRIBE

RNA editing

A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: GSK, Alnylam, Sanofi and More
On the agenda for the FDA this month are two RNA-based treatments for rare diseases.
March 10, 2025
 · 
7 min read
 · 
Tristan Manalac
Ribonucleic acid strands consisting of nucleotides important for protein bio-synthesis - 3d illustration
Drug Development
RNA Editing Hits the Clinic, Fueling New Hope for Rare and Common Diseases
With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery breakthroughs are needed to propel RNA editing to the next stage.
February 24, 2025
 · 
6 min read
 · 
Heather McKenzie